Venn Research Inc., Aug 2010, Pages: 435
years up to 2014.
The world pharmaceuticalsmarket generated total revenues of $644,204.4 million in 2009, representing a compound annual growth rate (CAGR) of 4.3% forthe period spanning 2005-2009. In
MarketLine, March 2012, Pages: 115
analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year
Espicom Business Intelligence Ltd, Dec 2011, Pages: 410
need:
This new report from Espicom is a key resource forthe wide assessment of 160 medium-sized generic companies operating in 35 markets worldwide. The report provides an essential and comprehensive
Datamonitor, Nov 2010, Pages: 153
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide The OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and
Global Industry Analysts, Inc, Feb 2012, Pages: 221
worldwide Gelatin marketin terms of production and consumption volumes, with Germany and Russia taking the lead as major gelatin markets in Western Europe. On the other hand, China and India tilt the growth
Datamonitor, Jan 2011, Pages: 156
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide ThePharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis
Frost & Sullivan, Dec 2011, Pages: 213
the same time, the balance in terms of healthcare expenditure and sales revenue is poised to shift from developed to emerging markets such as India, China, Brazil, Russia, Turkey and South Korea, as
MarketLine, Jan 2012, Pages: 131
covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market
MarketLine, March 2012, Pages: 758
individual chapters on Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore, South Africa
MarketLine, Jan 2012, Pages: 887
$733,104.8 million.
In 2015, the global pharmaceuticalsmarket is forecast to have a value of $981,050.8 million, an increase of 33.8% since 2010.
Americas accounts for 44.6% of the global pharmaceuticals
Espicom Business Intelligence Ltd, July 2011, Pages: 300
Europe?
- What have been the key trends affecting pharmaceutical technology companies in leading emerging markets such as India, China, Brazil and Russia?
Which other business reference provides
Axis Research Mind, Feb 2011, Pages: 550
& FORECASTS - (2009-2015, IN USD$ MILLION)
4. CARDIAC MEDICAL DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2009-2015, IN USD
Decision Resources, Inc., Aug 2011
developing Asia are all categorized as emerging and developing economies. Pharmaceutical companies mostly prioritize Brazil, Russia, India, China, Mexico, and Turkey (BRIC-MT) for their emerging market
BRICdata, March 2012, Pages: 155
solution helps companies cater to the growing demand for fresh, high quality products among Russian consumers.
- TheIndian sustainable packaging category valued US$X.XX billion in 2011 and is currently
Global Industry Analysts, Inc., Jan 2012, Pages: 443
therapeutic areas are expected to propel the global demand forPharmaceuticalsinthe following years.
Although considered largely recession-proof, as apparent by the performance of the pharmaceutical market
Espicom Business Intelligence Ltd, Feb 2012
Indonesia
Mexico
Russia
Turkey
TheMarketforPharmaceuticalsinBrazil, Russia, India & China
BrazilRussiaIndia
China
The Outlook forPharmaceuticalsinthe Middle East and North Africa
Egypt
Espicom Business Intelligence Ltd, Oct 2010, Pages: 472
Partnering inthe Global Generics Industry 2010 - A Guide to Companies "Facts, statistics and insights on 168 medium-sized generic manufacturers from 40 countries
The operating environment for
Decision Resources, Inc., June 2011
Opportunities in Emerging Markets - Central and Eastern Europe, Russia, and Ukraine What opportunities are available for pharmaceutical companies to pursue inthe emerging markets of Central and
GlobalData, March 2012, Pages: 345
) to 2017
Summary
GlobalData’s new report, “Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Advanced Wound
